Mankind Pharma targets early Semaglutide launch

Mankind Pharma is set to enter India's semaglutide market soon. The drug's patent expires this month, opening doors for new players. Mankind Pharma plans to offer the medication at affordable prices. This move aims to improve patient access to this important therapy. The company sees a significant opportunity as semaglutide's use extends beyond diabetes to other health areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tyGXjwh
via IFTTT